Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults
Authors
Discussion
Loading...
Member takes
Implication
May guide updated secondary prevention in elderly CHD; leaves open optimal strategies for those ≥75 years.
Key Points
- To update recommendations on secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in light of an expanding older adult demographic and rising healthcare burdens.
- Analyzed epidemiological projections and demographic shifts in US adults aged ≥65, ≥75, and ≥85 years with established cardiovascular conditions.
- Assessed health outcomes, functional impairment risks, and projected direct and indirect economic costs associated with ASCVD through 2050.
- Adults aged ≥75 years accounted for 67% of the 811,940 cardiovascular deaths in the US in 2008, with over half of the 16.3 million coronary heart disease cases occurring in individuals >65 years.
- Annual US direct costs for ASCVD are projected to escalate from $84.8 billion in 2015 to $202 billion by 2030, compounded by substantial indirect costs driven by loss of functional independence.
Cite This Study
Fleg et al. (2013) studied this question.